International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 101–200 of 1,132
Ozarda, Y., Sikaris, K., Streichert, T., Macri, J., & on behalf of IFCC Committee on Reference intervals and Decision Limits (C-RIDL) (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1482256 · Cited by 212
Vitamin D and Gestational Diabetes: A Systematic Review and Meta-Analysis
Poel, Y. H. M., Hummel, P., Lips, P., Stam, F., van der Ploeg, T., & Simsek, S. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.01.007 · Cited by 211
“However, screening and diagnostic tests for GDM are not uniform worldwide [4,8].”
BackgroundMethodInfluentialDiagnosing gestational diabetes
Ryan, E. A. (2011) · Diabetologia · doi:10.1007/s00125-010-2005-4 · Cited by 205
“The proposed IADPSG diagnostic criteria are not based on a composite of these benefits, they are based on LGA, cord C-peptide and fetal adiposity, and for LGA the BMI level may be a better predictor than glucose alone [5, 32].”
InfluentialBouchard, L., Hivert, M.-F., Guay, S.-P., St-Pierre, J., Perron, P., & Brisson, D. (2012) · Diabetes · doi:10.2337/db11-1160 · Cited by 210
Review of methods for detecting glycemic disorders
Bergman, M., Abdul-Ghani, M., DeFronzo, R. A., Manco, M., Sesti, G., Fiorentino, T. V., Ceriello, A., Rhee, M., Phillips, L. S., Chung, S., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108233 · Cited by 199
Physical Activity and Pregnancy: Past and Present Evidence and Future Recommendations
Downs, D. S., Chasan‐Taber, L., Evenson, K. R., Leiferman, J. A., & Yeo, S. (2012) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2012.10599138 · Cited by 248
TEH, W. T., TEEDE, H. J., PAUL, E., HARRISON, C. L., WALLACE, E. M., & ALLAN, C. (2011) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2011.01292.x · Cited by 196
Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202
Gestational diabetes: risks, management, and treatment options
Kim, C. (2010) · International Journal of Women's Health · doi:10.2147/ijwh.s13333 · Cited by 192
Gestational diabetes from A to Z
Mirghani Dirar, A., & Doupis, J. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i12.489 · Cited by 198
Consequences of gestational and pregestational diabetes on placental function and birth weight
Vambergue, A., & Fajardy, I. (2011) · World Journal of Diabetes · doi:10.4239/wjd.v2.i11.196 · Cited by 188
Yuen, L., Saeedi, P., Riaz, M., Karuranga, S., Divakar, H., Levitt, N., Yang, X., & Simmons, D. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107841 · Cited by 179
Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk Factors
Pu, J., Zhao, B., Wang, E. J., Nimbal, V., Osmundson, S., Kunz, L., Popat, R. A., Chung, S., & Palaniappan, L. P. (2015) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12209 · Cited by 181
Diet and exercise interventions for preventing gestational diabetes mellitus
Bain, E., Crane, M., Tieu, J., Han, S., Crowther, C. A., & Middleton, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010443.pub2 · Cited by 188
H. Al Wattar, B., Dodds, J., Placzek, A., Beresford, L., Spyreli, E., Moore, A., Gonzalez Carreras, F. J., Austin, F., Murugesu, N., Roseboom, T. J., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002857 · Cited by 168
Viana, L. V., Gross, J. L., & Azevedo, M. J. (2014) · Diabetes Care · doi:10.2337/dc14-1530 · Cited by 187
Callaway, L. K., McIntyre, H. D., Barrett, H. L., Foxcroft, K., Tremellen, A., Lingwood, B. E., Tobin, J. M., Wilkinson, S., Kothari, A., Morrison, M., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2248 · Cited by 187
“The primary outcome of the study was the frequency of GDM at 28 weeks’ gestation by a 75-g OGTT using the World HealthOrganization–endorsed criteria of the International Association of the Diabetes and Pregnancy StudyGroups (30).”
BackgroundUpdate on Diabetes Classification
Thomas, C. C., & Philipson, L. H. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.015 · Cited by 180
Oostdam, N., van Poppel, M., Wouters, M., Eekhoff, E., Bekedam, D., Kuchenbecker, W., Quartero, H., Heres, M., & van Mechelen, W. (2012) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2012.03366.x · Cited by 176
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Landon, M. B., & Gabbe, S. G. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31823974e2 · Cited by 175
Gestational diabetes: risk factors and recent advances in its genetics and treatment
Petry, C. J. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510001741 · Cited by 180
Kijmanawat, A., Panburana, P., Reutrakul, S., & Tangshewinsirikul, C. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.12863 · Cited by 174
Issues with the diagnosis and classification of hyperglycemia in early pregnancy
McIntyre, H. D., Sacks, D. A., Barbour, L. A., Feig, D. S., Catalano, P. M., Damm, P., & McElduff, A. (2016) · Diabetes Care · doi:10.2337/dc15-1887 · Cited by 181
“In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) panel published consensus-based recommendations on the diagnosis and classification of hyperglycemia in pregnancy (1).”
BackgroundAgarwal, M. M., Dhatt, G. S., & Shah, S. M. (2010) · Diabetes Care · doi:10.2337/dc10-0572 · Cited by 181
Mackillop, L., Hirst, J. E., Bartlett, K. J., Birks, J. S., Clifton, L., Farmer, A. J., Gibson, O., Kenworthy, Y., Levy, J. C., Loerup, L., et al. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9512 · Cited by 181
“Screening for GDM was based on risk factors as per UK clinical guidelines [15] and GDM was defined using the International Association of Diabetes and Pregnancy Study Group [16] criteria.”
MethodGestational Diabetes Mellitus in Europe: A Systematic Review and Meta-Analysis of Prevalence Studies
Paulo, M. S., Abdo, N. M., Bettencourt-Silva, R., & Al-Rifai, R. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.691033 · Cited by 181
Savvidou, M., Nelson, S. M., Makgoba, M., Messow, C.-M., Sattar, N., & Nicolaides, K. (2010) · Diabetes · doi:10.2337/db10-0688 · Cited by 178
Ovesen, P. G., Jensen, D. M., Damm, P., Rasmussen, S., & Kesmodel, U. S. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.966677 · Cited by 174
Lowe, L. P., Metzger, B. E., Lowe, W. L., Dyer, A. R., McDade, T. W., & McIntyre, H. D. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1662 · Cited by 171
Gestational diabetes mellitus: Challenges for different ethnic groups
Yuen, L. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1024 · Cited by 176
Nehring, I., Chmitorz, A., Reulen, H., von Kries, R., & Ensenauer, R. (2013) · Diabetic Medicine · doi:10.1111/dme.12286 · Cited by 173
Type 2 diabetes after gestational diabetes: The influence of changing diagnostic criteria
Noctor, E. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.234 · Cited by 165
Wickens, K. L., Barthow, C. A., Murphy, R., Abels, P. R., Maude, R. M., Stone, P. R., Mitchell, E. A., Stanley, T. V., Purdie, G. L., Kang, J. M., et al. (2017) · British Journal of Nutrition · doi:10.1017/s0007114517000289 · Cited by 172
Moses, R. G., Morris, G. J., Petocz, P., San Gil, F., & Garg, D. (2011) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2011.tb03001.x · Cited by 175
The Oral Glucose Tolerance Test: 100 Years Later
Jagannathan, R., Neves, J. S., Dorcely, B., Chung, S. T., Tamura, K., Rhee, M., & Bergman, M. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s246062 · Cited by 152
D’Anna, R., Scilipoti, A., Giordano, D., Caruso, C., Cannata, M. L., Interdonato, M. L., Corrado, F., & Di Benedetto, A. (2013) · Diabetes Care · doi:10.2337/dc12-1371 · Cited by 166
Women’s experiences of a diagnosis of gestational diabetes mellitus: a systematic review
Craig, L., Sims, R., Glasziou, P., & Thomas, R. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-2745-1 · Cited by 171
Dietary patterns before and during pregnancy and birth outcomes: a systematic review
Raghavan, R., Dreibelbis, C., Kingshipp, B. L., Wong, Y. P., Abrams, B., Gernand, A. D., Rasmussen, K. M., Siega-Riz, A. M., Stang, J., Casavale, K. O., et al. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy353 · Cited by 161
Patterns of Glycemia in Normal Pregnancy
Hernandez, T. L., Friedman, J. E., Van Pelt, R. E., & Barbour, L. A. (2011) · Diabetes Care · doi:10.2337/dc11-0241 · Cited by 170
von Eckardstein, A., & Minder, E. (2012) · Klinikhandbuch Labordiagnostische Pfade · doi:10.1515/9783110228731.80 · Cited by 168
Farrar, D., Fairley, L., Santorelli, G., Tuffnell, D., Sheldon, T. A., Wright, J., van Overveld, L., & Lawlor, D. A. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00255-7 · Cited by 165
Treatments for gestational diabetes: A systematic review and meta-analysis
Farrar, D., Simmonds, M., Bryant, M., Sheldon, T. A., Tuffnell, D., Golder, S., & Lawlor, D. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015557 · Cited by 163
Gestational Diabetes Mellitus in Africa: A Systematic Review
Macaulay, S., Dunger, D. B., & Norris, S. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097871 · Cited by 163
“International Association of Diabetes and Pregnancy Study Groups (IADPSG) [42] 2 hr 75 g OGTT At least one of the following must be met:”
BackgroundInfluentialHarrison, C. L., Lombard, C. B., Strauss, B. J., & Teede, H. J. (2013) · Obesity · doi:10.1002/oby.20163 · Cited by 153
“IADPSG criteria include a fasting venous plasma glucose of 91.8 mg/dl ( 5.1mmol/l), a 1-h plasma glucose of 180 mg/dl ( 10.0 mmol/l), or a 2-h glucose level of 153 mg/dl ( 8.5 mmol/l) (26).”
MethodInfluentialHowe, C. G., Cox, B., Fore, R., Jungius, J., Kvist, T., Lent, S., Miles, H. E., Salas, L. A., Rifas-Shiman, S., Starling, A. P., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0524 · Cited by 161
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 208
Garnæs, K. K., Mørkved, S., Salvesen, Ø., & Moholdt, T. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002079 · Cited by 161
“3%) in the control group had developed GDM according to the WHO 2009 definition [27], with a statistical difference between groups (p = 0.”
MethodResultPostpartum screening for diabetes among women with a history of gestational diabetes mellitus.
Tovar, A., Chasan‐Taber, L., Eggleston, E., & Oken, E. (2011) · Preventing Chronic Disease · Cited by 202
Combined effects of maternal age and parity on successful initiation of exclusive breastfeeding
Kitano, N., Nomura, K., Kido, M., Murakami, K., Ohkubo, T., Ueno, M., & Sugimoto, M. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.12.010 · Cited by 197
Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear
Cundy, T., Ackermann, E., & Ryan, E. A. (2014) · BMJ · doi:10.1136/bmj.g1567 · Cited by 158
Insulin for the treatment of women with gestational diabetes
Brown, J., Grzeskowiak, L., Williamson, K., Downie, M. R., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012037.pub2 · Cited by 158
Metabolic fingerprint of Gestational Diabetes Mellitus
Dudzik, D., Żórawski, M., Skotnicki, M., Zarzycki, W., Kozłowska, G., Bibik-Malinowska, K., Vallejo, M., García, A., Barbas, C., & Ramos, P. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.03.025 · Cited by 174
Lacroix, M., Battista, M., Doyon, M., Houde, G., Ménard, J., Ardilouze, J., Hivert, M., & Perron, P. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0564-4 · Cited by 177
Barakat, R., Refoyo, I., Coteron, J., & Franco, E. (2019) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2018.11.005 · Cited by 135
Sleep Quality and Nocturnal Sleep Duration in Pregnancy and Risk of Gestational Diabetes Mellitus
Cai, S., Tan, S., Gluckman, P. D., Godfrey, K. M., Saw, S.-M., Teoh, O. H., Chong, Y.-S., Meaney, M. J., Kramer, M. S., Gooley, J. J., et al. (2017) · Sleep · doi:10.1093/sleep/zsw058 · Cited by 157
Maternal outcomes and follow‐up after gestational diabetes mellitus
Kim, C. (2014) · Diabetic Medicine · doi:10.1111/dme.12382 · Cited by 149
Black, M. H., Sacks, D. A., Xiang, A. H., & Lawrence, J. M. (2010) · Diabetes Care · doi:10.2337/dc10-1445 · Cited by 160
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia
(2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.01.024 · Cited by 155
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors
Yang, Y., & Wu, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831297 · Cited by 155
Chakera, A. J., Spyer, G., Vincent, N., Ellard, S., Hattersley, A. T., & Dunne, F. P. (2014) · Diabetes Care · doi:10.2337/dc13-2248 · Cited by 154
Different strategies for diagnosing gestational diabetes to improve maternal and infant health
Farrar, D., Duley, L., Dowswell, T., & Lawlor, D. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007122.pub4 · Cited by 153
Thyroid hormones in diabetes, cancer, and aging
Gauthier, B. R., Sola‐García, A., Cáliz‐Molina, M. Á., Lorenzo, P. I., Cobo‐Vuilleumier, N., Capilla‐González, V., & Martín‐Montalvo, A. (2020) · Aging Cell · doi:10.1111/acel.13260 · Cited by 171
“Gestational DM is a common complication that affects ~10% of all pregnancies associated with adverse pregnancy outcomes, such as preeclampsia, macrosomia, and caesarean delivery (International Association of Diabetes, 2010; Petra et al., 2019).”
BackgroundFalavigna, M., Schmidt, M. I., Trujillo, J., Alves, L. F., Wendland, E. R., Torloni, M. R., Colagiuri, S., & Duncan, B. B. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.002 · Cited by 152
“[3] Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al.”
Backgroundon behalf of the DALI Core Investigator group, Egan, A. M., Vellinga, A., Harreiter, J., Simmons, D., Desoye, G., Corcoy, R., Adelantado, J. M., Devlieger, R., Van Assche, A., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4353-9 · Cited by 152
“Women in this study were diagnosed according to the IADPSG/WHO 2013 criteria [1, 3].”
BackgroundMethodInfluentialGenetics and Epigenetics: New Insight on Gestational Diabetes Mellitus
Dalfrà, M. G., Burlina, S., Vescovo, G. G. D., & Lapolla, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.602477 · Cited by 169
The relationship between maternal glycemia and perinatal outcome
Landon, M. B., Mele, L., Spong, C. Y., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318203ebe0 · Cited by 150
Spaight, C., Gross, J., Horsch, A., & Puder, J. J. (2016) · Endocrine Development · doi:10.1159/000439413 · Cited by 148
Excessive Gestational Weight Gain
McDowell, M., Cain, M. A., & Brumley, J. (2019) · Journal of Midwifery & Women's Health · doi:10.1111/jmwh.12927 · Cited by 133
Management of Diabetes in Pregnancy
Ballas, J., Moore, T. R., & Ramos, G. A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0249-0 · Cited by 151
Air Pollution Exposure and Abnormal Glucose Tolerance during Pregnancy: The Project Viva Cohort
Fleisch, A. F., Gold, D. R., Rifas-Shiman, S. L., Koutrakis, P., Schwartz, J. D., Kloog, I., Melly, S., Coull, B. A., Zanobetti, A., Gillman, M. W., et al. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307065 · Cited by 144
Guo, L., Ma, J., Tang, J., Hu, D., Zhang, W., & Zhao, X. Q. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9804708 · Cited by 157
“The presence of GDM always accompanies an increased maternal risk for preeclampsia and cesarean section and with an increased risk for developing type 2 diabetes (T2D) after pregnancy [2].”
BackgroundJamilian, M., Mirhosseini, N. Z., Eslahi, M., Bahmani, F., Shokrpour, M., Chamani, M., & Asemi, Z. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2258-y · Cited by 158
Hernandez, T. L., Van Pelt, R. E., Anderson, M. A., Daniels, L. J., West, N. A., Donahoo, W. T., Friedman, J. E., & Barbour, L. A. (2014) · Diabetes Care · doi:10.2337/dc13-2411 · Cited by 141
Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Kubik, M., et al. (2021) · JAMA · doi:10.1001/jama.2021.11922 · Cited by 127
Poston, L., Briley, A. L., Barr, S., Bell, R., Croker, H., Coxon, K., Essex, H. N., Hunt, C., Hayes, L., Howard, L. M., et al. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-148 · Cited by 140
“5 mmol/L according to the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) guidelines [25].”
MethodDietary advice interventions in pregnancy for preventing gestational diabetes mellitus
Tieu, J., Shepherd, E., Middleton, P., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006674.pub3 · Cited by 130
Nakshine, V. S., & Jogdand, S. (2023) · Cureus · doi:10.7759/cureus.47500 · Cited by 194
“Even among the vast majority of women who do not have autoimmunity or monogenic diabetes, there is significant variation in GDM. Metzger et al. [14] 2010 This paper can be used as the basis for internationally recognized guidelines for the diagnosis and classification of diabetes during gestation…”
BackgroundMethodD'Anna, R., Di Benedetto, A., Scilipoti, A., Santamaria, A., Interdonato, M. L., Petrella, E., Neri, I., Pintaudi, B., Corrado, F., & Facchinetti, F. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000958 · Cited by 131
He, J.-R., Yuan, M.-Y., Chen, N.-N., Lu, J.-H., Hu, C.-Y., Mai, W.-B., Zhang, R.-F., Pan, Y.-H., Qiu, L., Wu, Y.-F., et al. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515000707 · Cited by 130
Perak, A. M., Lancki, N., Kuang, A., Labarthe, D. R., Allen, N. B., Shah, S. H., Lowe, L. P., Grobman, W. A., Lawrence, J. M., Lloyd-Jones, D. M., et al. (2021) · JAMA · doi:10.1001/jama.2021.0247 · Cited by 139
Ma, R. C. W., Schmidt, M. I., Tam, W. H., McIntyre, H. D., & Catalano, P. M. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30278-9 · Cited by 125
Muche, A. A., Olayemi, O. O., & Gete, Y. K. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-2759-8 · Cited by 157
Metabolic profiling of gestational diabetes in obese women during pregnancy
on behalf of the UPBEAT Consortium, White, S. L., Pasupathy, D., Sattar, N., Nelson, S. M., Lawlor, D. A., Briley, A. L., Seed, P. T., Welsh, P., & Poston, L. (2017) · Diabetologia · doi:10.1007/s00125-017-4380-6 · Cited by 132
Diabetes and obesity in pregnancy
Simmons, D. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.10.006 · Cited by 134
Dietary Patterns during Pregnancy Are Associated with Risk of Gestational Diabetes Mellitus
Shin, D., Lee, K., & Song, W. (2015) · Nutrients · doi:10.3390/nu7115472 · Cited by 133
Hyperglycemia in pregnancy: prevalence, impact, and management challenges
Farrar, D. (2016) · International Journal of Women's Health · doi:10.2147/ijwh.s102117 · Cited by 129
Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence
Alesi, S., Ghelani, D. P., Rassie, K. L., & Mousa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115512 · Cited by 152
“However, the International Association of Diabetes and Pregnancy Study Group (IADPSG) also recommends screening for overt diabetes at the first antenatal visit [11].”
BackgroundColagiuri, S., Falavigna, M., Agarwal, M. M., Boulvain, M., Coetzee, E., Hod, M., Meltzer, S. J., Metzger, B., Omori, Y., Rasa, I., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.02.012 · Cited by 132
Diabetes in pregnancy: a new decade of challenges ahead
the Diabetic Pregnancy Study Group, Schaefer-Graf, U., Napoli, A., & Nolan, C. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4545-y · Cited by 118
Epigenetic programming, early life nutrition and the risk of metabolic disease
Block, T., & El-Osta, A. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.09.003 · Cited by 130
Allard, C., Desgagné, V, Patenaude, J., Lacroix, M., Guillemette, L., Battista, M., Doyon, M., Ménard, J., Ardilouze, J., Perron, P., et al. (2015) · Epigenetics · doi:10.1080/15592294.2015.1029700 · Cited by 125
Type 2 Diabetes and Indigenous Peoples
Crowshoe, L. L., Dannenbaum, D. A., Green, M., Henderson, R., Hayward, M. N., & Toth, E. L. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.022 · Cited by 148
Hyperglycemia and Adverse Pregnancy Outcomes
Metzger, B. E., Coustan, D. R., & Trimble, E. R. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.303990 · Cited by 121
The Harbin Consensus Conference Workshop Group, Chairs:, C., Legro, R. S., Wu, X., Scientific Committee:, Barnhart, K. T., Farquhar, C., Fauser, B. C. J. M., Mol, B., Legro, R. S., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu218 · Cited by 129
Ronald, C. W., Tutino, G., Lillycrop, K. A., Hanson, M. A., & Tam, W. H. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.02.010 · Cited by 145
Du, Y., Rafferty, A. R., McAuliffe, F. M., Wei, L., & Mooney, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-05112-2 · Cited by 128
Muche, A. A., Olayemi, O. O., & Gete, Y. K. (2019) · Archives of Public Health · doi:10.1186/s13690-019-0362-0 · Cited by 128
Gestational diabetes mellitus: An update on the current international diagnostic criteria
Agarwal, M. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.782 · Cited by 128
Type 2 diabetes and cardiovascular disease in women
Norhammar, A., & Schenck-Gustafsson, K. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2694-y · Cited by 136
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.